1)Ohmiya N, Yano T, Yamamoto H, et al. Diagnosis and treatment of obscure GI bleeding at double balloon endoscopy. Gastrointest Endosc 66:S72-77, 2007
2)岡志郎,田中信治,宍戸孝好,他.出血性小腸疾患に対する診断・治療の進め方.胃と腸 45:312-320, 2010
3)山本博徳,緒方晴彦,松本主之,他.小腸内視鏡ガイドライン.Gastroenterol Endosc 57:2686-2720, 2015
4)大腸癌研究会(編).大腸癌取扱い規約,第9版.金原出版,2018
5)Chen CC, Neugut AI, Rotterdam H. Risk factors for adenocarcinomas and malignant carcinoids of the small intestine:preliminary findings. Cancer Epidemiol Biomarkers Prev 3:205-207, 1994
6)Haubrich WS, Schaffner F, Berk JE. Bockus Gastroenterology, 5th ed, Vol. 2. WB Saunders, Philadelphia, pp 1274-1290, 1995
7)八尾恒良,八尾建史,真武弘明,他.小腸腫瘍—最近5年間(1995〜1999)の本邦報告例の集計.胃と腸 36:871-881, 2001
8)Mitsui K, Tanaka S, Yamamoto H, et al. Role of double-balloon endoscopy in the diagnosis of small-bowel tumors:the first Japanese multicenter study. Gastrointest Endosc 70:498-504, 2009
9)川井啓市,馬場忠雄,赤坂裕三,他.わが国における小腸疾患の現況と展望.胃と腸 11:145-155, 1976
10)濱田義浩,二村聡.小腸悪性腫瘍の臨床病理学的特徴—小腸原発性上皮性悪性腫瘍(癌腫)の臨床病理学的検討.胃と腸 48:1380-1391, 2013
11)Raghav K, Overman MJ. Small bowel adenocarcinomas—existing evidence and evolving paradigms. Nat Rev Clin Oncol 10:534-544, 2013
12)Aparicio T, Henriques J, Manfredi S, et al. Small bowel adenocarcinoma:Results from a nationwide prospective ARCAD-NADEGE cohort study of 347 patients. Int J Cancer 147:967-977, 2020
13)Tsuboi A, Urabe Y, Oka S, et al. Genomic analysis for the prediction of prognosis in small-bowel cancer. PLoS One 16:e0241454, 2021
14)Sakae H, Kanzaki H, Nasu J, et al. The characteristics and outcomes of small bowel adenocarcinoma:a multicentre retrospective observational study. Br J Cancer 117:1607-1613, 2017
15)岡志郎,田中信治,飯尾澄夫,他.小腸の腫瘍性・腫瘍様疾患—原発性小腸癌と転移性小腸腫瘍.胃と腸 54:451-460, 2019
16)多田修治,上原正義.12.腫瘍性病変A-1.上皮性腫瘍2)小腸癌.八尾恒良,飯田三雄(編).小腸疾患の臨床.医学書院,pp 326-331, 2004
17)Tang SJ, Zanati S, Dubcenco E, et al. Capsule endoscopy regional transit abnormality:a sign of underlying small bowel pathology. Gastrointest Endosc 58:598-602, 2003
18)岡志郎,田中信治,野田育江,他.小腸腫瘍をめぐって—小腸悪性腫瘍:GIST.Intestine 15:143-150, 2011